Exposure to traffic-related air pollutants (TRAPs) has been implicated in asthma development, persistence, and exacerbation. This exposure is highly significant because increasingly large segments of the population worldwide reside in zones that have high levels of TRAP, including children, as schools are often located in high traffic pollution exposure areas.
INTRODUCTION
A recent comprehensive and systematic review of worldwide traffic emissions and health science by a Special Panel convened by the Health Effects Institute found sufficient evidence that exposure to traffic-related air pollutants (TRAPs) causes asthma exacerbation in children [1] . Within the complex mixture of gaseous and particulate components of TRAP, diesel exhaust particles (DEPs) are of particular concern with respect to health effects. DEPs are estimated to contribute up to 90% of the particulate matter derived from traffic sources, are primarily ultrafine in size (<100 nm), can be deposited in the nasal and peripheral airways, and have been shown to induce oxidative stress and airway hyperresponsiveness (AHR), and enhance allergic responses and airway inflammation [2] [3] [4] . This exposure is highly significant because in large cities in North America, up to 45% of the population resides in zones that are most impacted by TRAP [1] and over 30% of schools are located in high TRAP exposure areas [5] . Evidence from our group and others suggests that TRAP is also associated with reduced lung growth and the development of asthma, though recent studies have reported conflicting results [6] [7] [8] [9] 10 && , 11, 12 && ]. These inconsistent findings may be because of a lack of knowledge regarding the mechanistic basis of TRAP health effects and the characteristics of those most susceptible to the harmful effects of TRAP exposure. Recent epidemiologic and mechanistic findings have started to fill gaps in knowledge regarding the health impact of TRAP exposure on allergic diseases, as well as the molecular mechanisms by which TRAP leads to adverse effects on allergic diseases such as asthma. Further, new methodologies for the quantification of TRAP hold tremendous promise for rapid and reliable identification of individuals at-risk because of high exposure. The prevalence and incidence of allergic diseases have been increasing worldwide since the 1960s [13, 14] . More recent investigators suggest that asthma prevalence has plateaued in developed countries, whereas in developing countries, where the prevalence was previously low, allergic diseases are on the rise [15] . Environmental changes are suspected to be the major driver of this increasing trend [16] , with air pollution identified as an important extrinsic agent [17] . Motor vehicles produce a complex mixture of air pollutants including carbon monoxide, nitrogen oxides, particulate matter of varying size, polycyclic aromatic hydrocarbons [PAHs; e.g., benzo(a)pyrene], volatile organic compounds (VOCs; e.g., benzene and acetaldehyde), and other hazardous air pollutants. Collectively referred to as TRAPs, these are the primary source of intraurban variability in air pollutant concentrations [1] .
Asthma and wheezing
There is sufficient evidence to suggest that TRAP can decrease lung function and trigger asthma exacerbation and hospitalizations [14, 18] . Recent large studies on TRAP and respiratory outcomes substantiate these conclusions (Table 1) 16 communities, indicate that exposure to higher local nitrogen dioxide (NO 2 ) concentrations and close residential proximity to a freeway increase asthma prevalence [19] . Asthmatic children in the cohort who lived in communities with higher levels of NO 2 , PM 10 and PM 2.5 had increased chronic lower respiratory symptoms, phlegm, production, bronchitis, wheeze, and medication use [19] . Living in areas with higher air pollution markers also affected lung function and growth. Children aged 10-18 years living within 500 m of a freeway had significant deficits in forced expiratory volume in 1 second, forced vital capacity (FVC), and maximal mid-expiratory flow rate compared with those living more than 1500 m away [19] . A recent study of 5443 Korean children aged 6-14 years found that children living within 200 m of a main road that was at least 254 m long had increased lifetime wheezing, lifetime asthma diagnosis, and decreased lung function [20] . A metaanalysis of six cohorts in the European Study of Cohorts for Air Pollution Effects (ESCAPE) that included 23 704 adults found that exposure to higher NO 2 increased the incidence of adult-onset asthma, although the results did not reach significance [21 && ]. ESCAPE was also composed of five birth cohort studies including 17 041 children. Although these birth cohorts did not find any significant associations between six traffic-related pollution metrics and childhood asthma prevalence, the land-use regression (LUR) models used to estimate exposures were carried out as long as 15 years after the asthma outcomes were collected [10 && ]. During this time, campaigns to reduce air pollution could have reduced exposure levels compared with those present when the asthma outcomes were collected. We have also shown TRAP exposure levels at a child's birth address to be associated with wheezing [22] [23] [24] and recurrent night cough [25] in the first 3 years of life.
Allergic sensitization and eczema
Studies also support an increase in allergic sensitization and eczema with TRAP exposures (Table 1) . A 2014 review of epidemiologic data on the role of air pollution in eczema concluded that a variety of air pollutants, including those related to TRAP such as particulate matter and nitrogen oxides, act as risk factors for the development or aggravation of eczema [26 & ]. A study of 4907 children aged 9-11 years showed that lifetime eczema was significantly associated with 3-year averaged concentrations of PM 10 , NO 2 , NO X , and CO [27] . A Taiwanese study of 317 926 middle school students demonstrated that flexural eczema was associated with levels of CO and NO X [28] . In the Southern California Children's Health Study, children living less than 75 m from the main road were significantly more likely to have lifetime diagnoses and symptoms of allergic rhinitis [20] . The distance to the main road, and the length and proportion of the main road within 200 m of the home, were all associated with allergic sensitization, defined as a positive skin prick test to an aeroallergen or food [20] . Our data and others have also shown high TRAP exposure in the first year of life to increase the risk of aeroallergen sensitization by the age of 4 by 40-83% [29
&&
,30]. Children exposed to high TRAP levels before age 1 also have an increased risk of developing food allergy by age 8, particularly those who are not sensitized at age 4 [30] .
Insights from birth cohort studies
To evaluate the impact of TRAP on asthma and allergy development, birth cohort studies are needed (Table 1) . A recent meta-analysis conducted a systematic review of birth cohort studies to understand the association between early childhood TRAP and subsequent allergies, asthma, and allergic sensitization [12 && ]. Although modest associations were observed between asthma incidence/prevalence and wheeze and nitrogen oxides, particulate matter, black carbon, and road proximity, there was substantial heterogeneity observed (likely because of differences in study design, participants and exposure, and outcome definitions) between the studies [12 && ]. The meta-analyses showed no association with TRAP measures and sensitization to indoor allergens (cat, dog, or mold). Although there was a significant association between particulate matter and sensitization to outdoor allergens (pollen and grass), there was again high heterogeneity between studies [12 && ]. The associations between the markers of air pollution (NO 2 , black carbon, and road proximity) and hay fever and eczema were inconsistent. With respect to the timing of exposure and disease development, this review suggests that TRAP exposure is associated with new onset asthma and may have an ongoing effect with a lag time of about 3 years [12 && ]. We recently reported that a child's risk for persistent wheeze and asthma development varies depending on the timing and duration of TRAP exposure [31 && ]. Children exposed to high levels of TRAP at the time of birth were nearly twice as likely to experience persistent wheezing at age 7; however, a longer duration of exposure to high levels of TRAP (beginning early in life and continuing through age 7) was the only time period of exposure related to asthma development [31 && ]. Collectively, there is considerable evidence that TRAP plays a role in the development, and symptoms of allergic disease. However, heterogeneity in both the definitions of TRAP exposure and outcomes, and unmeasured confounding, limit the ability to draw firm conclusions from the data. As discussed in the Bowatte et al. [12 && ] meta-analyses, there is substantial variability in the exposure measurements across TRAP-related studies. LUR models are among the most common methods to assess TRAP exposures. Other methods include passive samplers, central monitoring stations, and proximity to major roads. The most frequent markers of pollutants include particulate matter, oxides of nitrogen, carbon monoxide, and ozone. Particulate matter may be further reported as black carbon, PM 10 , or PM 2.5 . Although this vast variation in the definition of TRAP exposure limits the ability to conduct sound meta-analyses, it highlights the importance of appropriate exposure assessment, as discussed below.
ASSESSMENT OF TRAFFIC-RELATED AIR POLLUTANT EXPOSURE
Given the increasingly evident health impact of TRAP, methodologies to accurately assess exposure are needed. Although TRAP affects air quality on urban and regional scales, their impact is greatest on a local scale, particularly near roadways, as their concentrations are significantly elevated within approximately 300-500 m of their source [32] . Further influencing individuals' TRAP exposure is its temporal variability combined with complex and variable personal behavior including time spent indoors/outdoors [33] . In order to meet the intrinsic challenge of accurately assessing TRAP exposure for epidemiologic studies, both modeling and personal measurement approaches have been proposed. Herein, we briefly review approaches to TRAP exposure assessment for epidemiologic studies with an emphasis on recent methodologic advances. An overview of each approach and their strengths and limitations are also provided in Table 2 .
Modeling approaches
Although regulatory air monitoring provides valuable data to link the regional and temporal variability of air pollutants to population-level health outcomes, including increased cardiopulmonary morbidity and mortality [34] [35] [36] [37] , these networks are unable to capture the high spatial variability of TRAP concentrations within an urban area. Measuring proximity (i.e., distance) to major roadways is a straightforward approach to estimate TRAP exposure, though this method does not account for traffic density and other geographic and land-use characteristics which impact TRAP concentrations [38] . An alternative approach, dispersion modeling, has not been extensively utilized in epidemiologic studies because of the required data (e.g., meteorology, traffic volume, and makeup) and expertise required for its use [33] .
Among the most frequently used method to estimate TRAP exposure in epidemiologic studies is LUR modeling [38] [39] [40] [41] . In the most straightforward LUR approach, a single pollutant from the TRAP mixture is measured at multiple stationary sites within a defined study region and the characteristics of the area surrounding each sampling site (e.g., elevation, nearby roads, and traffic) are used as predictors of the measured concentrations in a linear model. The resultant LUR model is then applied to estimate pollutant concentrations at nonsampled locations, including schools and homes, where significant geographic predictor variables can be determined. First described by Briggs et al. [42] [55] [56] [57] [58] . New data inputs for LUR models, including satellitederived pollutant measurements [59, 60] , and the development of hybrid models combining LUR with Bayesian Maximum Entropy and other statistical approaches, have also improved the accuracy of TRAP exposure assessment [61, 62] . In studies with available participant-reported time spent in locations outside the home, LUR models have been used to derive time-weighted estimates of exposure ]. Another potential approach to assessing personal exposure to TRAP is the use of a measured biomarker of exposure in a biological specimen (e.g., urine or blood). Although measuring PAH metabolites as biomarkers of TRAP exposure has been conducted primarily in occupational settings, more recent studies have identified PAH metabolites specific to environmental traffic exposure making this approach more feasible for applications in environmental epidemiology [71] [72] [73] .
MECHANISTIC INSIGHTS INTO TRAFFIC-RELATED AIR POLLUTANT EFFECTS ON THE PATHOGENESIS OF ALLERGIC DISEASE
Although there is strong evidence that TRAP exposure contributes to childhood asthma [1, 6, 7, 24] , the mechanistic basis of TRAP effects on asthma has been elusive. The molecular and cellular pathways triggered by exposure to TRAP and their impact on allergen-induced immune responses have been studied in human studies as well as in reductionist models in vitro and in animal models in vivo.
Diesel exhaust particle induces epithelial stress responses
As the main barrier against airway pathogens and pollutants, lung epithelial cells are commonly used to study the toxicity of different traffic-related pollutants and their components and have been reviewed elsewhere [74, 75] . The inability of epithelial cells to effectively detoxify DEP results in release of proinflammatory cytokines including cytokines involved in T H 17 differentiation [interleukin-1 beta and IL6] and neutrophil chemokines, such as IL8 (CXCL8). DEP-mediated induction of IL8 is dependent on p38 MAP kinase and nuclear factor kappa B signaling [76] . Upstream, IL8 secretion has been shown to be dependent on the epidermal growth factor receptor (EGFR) pathway, as DEP induces secretion of endogenous EGFR ligands, and neutralizing antibodies against transforming growth factor alpha (TGFa), heparin-binding epidermal growth factor or amphiregulin decreases IL8 secretion by primary bronchial epithelial cells following DEP exposure [77] . As TGFa neutralizing antibodies or TNFa-converting enzyme [tumor necrosis factor-alpha-converting enzyme, also called ADAM metallopeptidase domain 17] inhibitors significantly decrease IL8 generation following DEP exposure, a model by which cleavage of pro-TGFa by TACE leads to EGFR signaling has been proposed [78, 79] . A similar cascade of events has been demonstrated for allergen (house dust mite)-mediated induction of granulocyte-macrophage colony-stimulating factor by human bronchial epithelial cells, underscoring that these pathways are part of a broad epithelial stress response (Fig. 1) .
Diesel exhaust particle exposure promotes T H 17 responses including increased T H 2/T H 17 double-producing cells
Although asthma has long been characterized as a disease of dysregulated T H 2 immune responses to environmental allergens, accumulating evidence suggests a role of T H 17 cells, especially in severe steroid-resistant asthma [80, 81] . Immunohistochemistry on bronchial biopsies from asthmatic patients reveals increased IL-17Aþ cells in patients with severe asthma compared with mild asthma or controls [82] . In both adults and children, serum IL-17A is significantly higher in severe asthmatic patients compared with mild asthmatic patients or controls [83] [84] [85] . Recent evidence demonstrates that DEP exposure promotes asthma by enhancing T H 17 immune responses, and anti-IL17A treatment alleviates the negative effects of DEP on asthma in a mouse asthma model [4] . Similarly, in children, TRAP exposure is associated with increased serum IL17A levels and increased asthma severity [4] . In mice, DEP exposure results in accumulation and persistence of allergen-specific T H 2/T H 17 cells in the lungs, potentiating secondary allergen recall responses [86 && ]. These cells rapidly produce both T H 2 and T H 17 cytokines upon re-exposure to antigen. The induction and persistence of these resident memory cells in the lungs following TRAP exposure may be responsible, in part, for the long lasting impact of early life TRAP exposure into later lifestages, and may contribute to the persistence of asthma into adolescence. Recent studies have demonstrated that dual-positive T H 2/T H 17 cells and IL-17A were present at a higher frequency in the broncho-alveolar lavage fluid from steroid-resistant asthmatic patients [87 && ]. These T H 2/T H 17 cells were resistant to dexamethasone-induced cell death and the T H 2/T H 17 predominant subgroup of patients manifested the most severe form of asthma [87 && ]. Thus, these double-producing cells may be an excellent biomarker of severe, steroid-resistant patients who would benefit from additional or alternate treatment. In a murine model, transfer of allergen-specific T H 2/T H 17 double-producing cells to naive mice resulted in inflammation and exacerbated asthma [88] .
Mice exposed to DEP alone develop airway neutrophilia, but do not present any of the hallmarks associated with asthma such as eosinophilia, T H 2 cytokine release, mucus production, or AHR [2, 4, 89] . However, chronic exposure to low doses of DEP over a 3-month period results in emphysema and accumulation of T cells [89] . DEP exposure promotes accumulation of T REG , T H 17 cells, and neutrophils [2, 4] . The observed increase in T Reg and Th17 cells may result in part from the ability of DEP to promote T H 17, T H 22, and T Reg differentiation through the aryl hydrocarbon receptor (AhR) [90, 91] . Indeed, exposure to DEP and related polycyclic PAHs has been shown to increase T H 22 cells in an Ahr-dependent manner [92, 93] . Ahr signaling requires dimerization with the aryl hydrocarbon receptor nuclear translocator(ARNT), also known as hypoxia-inducible factor beta. Accordingly, a cross-talk between the hypoxia-inducible factor 1-alpha (HIF1a) and Ahr pathways has been proposed, as both might compete for ARNT binding [94] . In T cells, HIF1a-driven glycolysis supports T H 17 differentiation by promoting expression of RORgt, whereas in conditions supporting T REG differentiation HIF1a favors Foxp3 induction [95, 96] . The respective contributions and interactions of DEP-induced Ahr signaling and oxidative stressrelated HIF1a signaling have not been explored. Failure to detoxify results in oxidative stress and release of repair cytokines (amphiregulin, TGFa), which signal through the epidermal growth factor receptor (EGFR), p38 mitogen-activated protein kinase, and NF-kB to induce secretion of chemokines, as well as cytokines involved in T H 17 and T H 2 differentiation (TSLP). DEP promotes allergic airway inflammation by upregulating the expression of the Jagged1/Notch1 pathway in dendritic cells (DCs) in an AhR-dependent manner in concert with allergens. DEP, diesel exhaust particle OVA, ovalbumin; TSLP, thymic stromal lymphopoietin.
Diesel exhaust particle exposure exacerbates allergen-induced T H 2 responses
Numerous studies have demonstrated that exposure to either particulate matter or DEP can exacerbate allergic airway responses [97] . We recently demonstrated that coexposure to house dust mite (HDM) and DEP promotes a mixed T H 2/T H 17 response with increased T H 2 and T H 17 cells, as well as doubleproducing IL13þ/IL17Aþ T H cells [2, 4] . Thus, DEP exposure exacerbates T H 2 responses. Mechanisms by which DEP exposure increases allergen-induced Th2 differentiation have been reviewed elsewhere [98] . A recent study using cocultures of ovalbumin (OVA) transgenic CD4
þ T cells and bone marrow-derived dendritic cells (BMDCs) pre-exposed to OVA with or without TRAP, demonstrated increased IFNg, IL4, IL13, and IL17 levels in culture supernatants of OVAþTRAP exposed BMDC compared with BMDC exposed to OVA alone [99 && ] supporting the idea that TRAP exposure directly impacts dendritic cells. Further, TRAP upregulated T H cytokine levels, IgE production, and allergic airway inflammation in mice in a Jagged1-dependent and Notch-dependent manner, and TRAP-induced Jagged1 expression was mediated by the AhR, which bound to and activated AhR response elements in the Jag1 promoter [ The impact of early life traffic-related air pollutant exposure
The timing and duration of TRAP exposure may be important for childhood wheezing and asthma development. This was examined in a recent article examining the relationship between TRAP exposure and longitudinal wheezing phenotypes and asthma at age 7 in a birth cohort [31 && ]. High TRAP exposure at birth was significantly associated with both transient and persistent wheezing. In contrast, only children with high average TRAP exposure continuously from birth through age 7 were at significantly increased risk for asthma [adjusted odds ratio ¼ 1.71, 95% confidence interval (CI) 1.01-2.88]. Early-life exposure to TRAP is associated with increased risk for persistent wheezing, but only long-term exposure to high levels of TRAP throughout childhood was associated with asthma development. In mice, postnatal exposure to HDM or DEP, followed by a secondary exposure to HDM 4 weeks later induced AHR only in mice that were coexposed to HDM and DEP but not in mice that were only exposed to HDM [86 && ]. In another study where neonatal ovalbumin-specific transgenic T cells-II mice were repeatedly pre-exposed to TRAP before being coexposed to OVA as adults, a secondary OVA recall response generated AHR only in mice previously coexposed to TRAP and OVA as neonates [101 & ]. This was associated with the accumulation of CD4 þ T cells expressing IL4 or IL17A in the lungs. Collectively, these data strongly suggest that TRAP exposure promotes disease persistence. Indeed, in the Cincinnati Childhood Allergy and Air Pollution Study birth cohort, early TRAP exposure was associated with persistent wheeze, whereas early and sustained exposure to TRAP was associated with asthma development [31 && ]. DEP exposure has been shown to enhance allergen-specific memory, thereby potentiating secondary allergen recall responses and promoting the development of allergic asthma [86 && ]. Prenatal TRAP exposure has been linked to asthma as well [102] [103] [104] [105] . Mothers who lived near highways during pregnancy are more likely to have children with asthma [103] . Prenatal exposure to PAHs is associated with an increased risk of allergic sensitization and early childhood wheeze [102, 105] . A limited number of mechanistic studies have assessed the impact of in-utero TRAP exposure on the development of allergic disorders. In one recent study, the offspring of mice exposed to DEP were hypersensitive to OVA and developed increased OVA sensitization, airway inflammation, Th2/Th17 responses, and AHR compared with offspring with no prior in-utero DEP exposure [106 && ]. Further, prenatal DEP exposure induced the expression of genes downstream of AhR and this upregulation persisted 1 month after birth, even though mice were no longer exposed to DEP. Thus, in-utero DEP exposure appears to result in a primed state where the neonate is hypersensitive to subsequent allergen exposure. Interestingly, the Th2 and Th17 cytokines were produced primarily by natural killer (NK) cells and other non-CD3 þ T cells. Repeated treatment with anti-NK1.1 prior to OVA challenge resulted in decreased airway inflammation [106 && ]. The importance of NK cells in allergic airway responses is supported by a recent study using NK-deficient mice [107] . The respective contribution of NK cells and other innate cells to DEP exacerbation of adaptive immune responses offers a promising new avenue of research.
CONCLUSION
As discussed above, there is considerable evidence that exposure to TRAP is associated with childhood asthma symptoms and exacerbations [6, 7, 10 && ,24,
108,109
&& ] and recent evidence suggests that TRAP is also associated with reduced lung growth and the development of asthma [31 && ]. Herein, we have reviewed the recent epidemiologic and mechanistic findings that have started to fill gaps in knowledge regarding the health impact of TRAP exposure on allergic diseases, as well as new methodologies for the quantification of TRAP that hold tremendous promise for rapid and reliable identification of individuals at-risk because of high exposure (Fig. 2) . These new methodologies will enable accurate assessment of exposure in real time such that interventions could be designed and implemented early in the course of exposure in vulnerable populations. The impact of TRAP exposure on allergic disease is complicated by the presence of additional host (genetic, obesity, comorbidities, and nutritional status) and environmental factors, which undoubtedly will affect the observed impact. Additional studies are needed to fill the remaining gaps, including the identification of the key host factors associated with enhanced susceptibility to TRAP exposure. These studies will have tremendous health impact and ultimately lead to design, testing, implementation, and dissemination of interventions to prevent the impact of TRAP exposure on asthma development, progression, and persistence. Overview. More accurate assessment of TRAP will enable the design of epidemiologic and mechanistic studies aimed at the discovery of biomarkers to identify the individuals most at-risk from the harmful effects of TRAP exposure and the design of novel-targeted interventions. LUR, land use regression; TRAP, traffic-related air pollutant.
